|
Delayed
Nasdaq
16:00:00 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 28.99 USD | -.--% |
|
-.--% | +235.14% |
| 08-30 | AstroNova, Inc.(NasdaqGM:ALOT) dropped from S&P TMI Index | CI |
| 08-27 | AstroNova, Inc.(NasdaqGM:ALOT) dropped from Russell Microcap Growth Benchmark Index | CI |
| Fiscal Period: January | 2017 (USD) | 2018 (USD) | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) | 2026 (USD) |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 117M | 143M | 148M | 151M | 151M | |||||
Total Revenues | 117M | 143M | 148M | 151M | 151M | |||||
Cost of Goods Sold, Total | 75.44M | 94.37M | 94.4M | 98.53M | 102M | |||||
Gross Profit | 42.04M | 48.16M | 53.68M | 52.75M | 48.93M | |||||
Selling General & Admin Expenses, Total | 33.83M | 35.19M | 35.44M | 40.18M | 36.65M | |||||
R&D Expenses | 7.05M | 6.82M | 6.88M | 6.61M | 6.79M | |||||
Other Operating Expenses, Total | 40.88M | 42.01M | 42.31M | 46.79M | 43.44M | |||||
Operating Income | 1.16M | 6.14M | 11.37M | 5.96M | 5.49M | |||||
Interest Expense, Total | -677K | -1.68M | -2.7M | -3.21M | -3.5M | |||||
Interest And Investment Income | - | - | - | - | - | |||||
Net Interest Expenses | -677K | -1.68M | -2.7M | -3.21M | -3.5M | |||||
Currency Exchange Gains (Loss) | -288K | -474K | -83K | 335K | -146K | |||||
Other Non Operating Income (Expenses) | -27K | 119K | 57K | -772K | -93K | |||||
EBT, Excl. Unusual Items | 164K | 4.11M | 8.65M | 2.32M | 1.75M | |||||
Restructuring Charges | - | - | -2.58M | - | -1.36M | |||||
Merger & Related Restructuring Charges | - | -700K | - | -1.2M | -1.23M | |||||
Impairment of Goodwill | - | - | - | -13.4M | -297K | |||||
Gain (Loss) On Sale Of Assets | -696K | - | - | - | - | |||||
Legal Settlements | - | - | - | - | -700K | |||||
Other Unusual Items | 7.57M | - | - | - | -700K | |||||
EBT, Incl. Unusual Items | 7.03M | 3.41M | 6.07M | -12.29M | -2.54M | |||||
Income Tax Expense | 605K | 749K | 1.38M | 2.2M | -160K | |||||
Earnings From Continuing Operations | 6.43M | 2.66M | 4.69M | -14.49M | -2.38M | |||||
Net Income to Company | 6.43M | 2.66M | 4.69M | -14.49M | -2.38M | |||||
Net Income - (IS) | 6.43M | 2.66M | 4.69M | -14.49M | -2.38M | |||||
Net Income to Common Incl Extra Items | 6.43M | 2.66M | 4.69M | -14.49M | -2.38M | |||||
Net Income to Common Excl. Extra Items | 6.43M | 2.66M | 4.69M | -14.49M | -2.38M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.89 | 0.36 | 0.63 | -1.93 | -0.31 | |||||
Basic EPS - Continuing Operations | 0.89 | 0.36 | 0.63 | -1.93 | -0.31 | |||||
Basic Weighted Average Shares Outstanding | 7.21M | 7.31M | 7.42M | 7.51M | 7.61M | |||||
Net EPS - Diluted | 0.88 | 0.36 | 0.63 | -1.93 | -0.31 | |||||
Diluted EPS - Continuing Operations | 0.88 | 0.36 | 0.63 | -1.93 | -0.31 | |||||
Diluted Weighted Average Shares Outstanding | 7.34M | 7.37M | 7.5M | 7.51M | 7.61M | |||||
Normalized Basic EPS | 0.01 | 0.35 | 0.73 | 0.19 | 0.14 | |||||
Normalized Diluted EPS | 0.01 | 0.35 | 0.72 | 0.19 | 0.14 | |||||
Dividend Per Share | - | - | - | - | - | |||||
Payout Ratio | - | - | - | - | - | |||||
Supplemental Items | ||||||||||
EBITDA | 5.15M | 10.06M | 15.64M | 10.74M | 10.3M | |||||
EBITA | 3.36M | 8.04M | 13.77M | 8.56M | 8.39M | |||||
EBIT | 1.16M | 6.14M | 11.37M | 5.96M | 5.49M | |||||
EBITDAR | 5.66M | 10.52M | 16.11M | 11.15M | 11M | |||||
Effective Tax Rate - (Ratio) | 8.6 | 21.96 | 22.71 | -17.92 | 6.31 | |||||
Current Domestic Taxes | -107K | 1.22M | 1.04M | 1.26M | 207K | |||||
Current Foreign Taxes | 501K | 870K | 420K | 153K | 1.02M | |||||
Total Current Taxes | 394K | 2.08M | 1.46M | 1.41M | 1.23M | |||||
Deferred Domestic Taxes | 357K | -1.37M | -30K | -634K | -991K | |||||
Deferred Foreign Taxes | -146K | 32K | -48K | 1.42M | -398K | |||||
Total Deferred Taxes | 211K | -1.34M | -78K | 790K | -1.39M | |||||
Normalized Net Income | 102K | 2.57M | 5.41M | 1.45M | 1.09M | |||||
Interest on Long-Term Debt | 677K | 1.68M | 2.7M | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 1.3M | 1.6M | 1.8M | 2M | 2M | |||||
Selling and Marketing Expenses | 23.98M | 24.46M | 24.03M | 25.56M | 22.72M | |||||
General and Administrative Expenses | 9.34M | 10.28M | 10.94M | 14.21M | 13.23M | |||||
Research And Development Expense From Footnotes | 6.75M | 6.82M | 6.91M | 6.61M | 6.79M | |||||
Net Rental Expense, Total | 510K | 460K | 470K | 410K | 702K | |||||
Imputed Operating Lease Interest Expense | 193K | 300K | 380K | 297K | 444K | |||||
Imputed Operating Lease Depreciation | 317K | 160K | 89.56K | 113K | 258K | |||||
Stock-Based Comp., G&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 1.49M | 1.29M | 1.35M | 1.38M | 2.31M | |||||
Total Stock-Based Compensation | 1.49M | 1.29M | 1.35M | 1.38M | 2.31M |
- Stock Market
- Stocks
- ALOT Stock
- Financials ASTRO MED
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















